Massachusetts · 194th Legislature (2025-2026) · Bill
H 2447: An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 2447 is a bill introduced in the Massachusetts House on February 27, 2025. According to its official title, it concerns: An Act authorizing a 90-day supply of medically necessary testosterone therapy medication. Primary sponsor: Natalie Higgins (Democratic). It lists 2 additional sponsors. Most recent recorded action (April 15, 2026): Committee recommended bill ought to pass and referred to the committee on House Ways and Means.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Representative Higgins of Leominster, a petition (accompanied by bill, House, No. 2447) of Natalie M. Higgins, Lindsay N. Sabadosa and James B. Eldridge relative to prescriptions for testosterone therapy medications. Public Health.
Sponsors
Sponsors by party (alphabetical): Democratic 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Natalie Higgins | Primary sponsor | Democratic | House | 4th Worcester |
| Jamie Eldridge | Co-sponsor | Democratic | Senate | Middlesex and Worcester |
| Lindsay Sabadosa | Co-sponsor | Democratic | House | 1st Hampshire |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Committee recommended bill ought to pass and referred to the committee on House Ways and Means
- Reporting date extended to Monday, June 15, 2026
- Reporting date extended to Wednesday, March 18, 2026
- Reported favorably by committee and referred to the committee on Health Care Financing
- Reporting date extended to Thursday, October 9, 2025
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Senate concurred
- Referred to the committee on Public Health